US Patent 10253370 High-sensitivity sequencing to detect BTK inhibitor resistance
Patent 10253370 was granted and assigned to Neogenomics on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10253370 High-sensitivity sequencing to detect BTK inhibitor resistance
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.